Insilico Medicine Appoints Jue Wang, PhD as Global Head of Business Development (IMAGE)

InSilico Medicine

Insilico Medicine Appoints Jue Wang, PhD as Global Head of Business Development

Caption

In the 2.75 billion-dollar deal with Eli Lilly announced in March 2026, Jue made significant contributions by leading the professional communication and cross-functional alignment, delivering another proof of AI possibilities and AI-driven quality. As the record-breaking collaboration drives significant attention and momentum, Insilico looks forward to wider communication with potential partners across the globe.

Credit

Insilico Medicine

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.